Institutional shares held 162 Million
11.5M calls
12.9K puts
Total value of holdings $151M
$10.7M calls
$11K puts
Market Cap $143M
153,231,008 Shares Out.
Institutional ownership 105.76%
# of Institutions 235


Latest Institutional Activity in IRWD

Top Purchases

Q1 2025
Exchange Traded Concepts, LLC Shares Held: 179K ($166K)
Q1 2025
Cerity Partners LLC Shares Held: 96.5K ($89.7K)
Q1 2025
Cwm, LLC Shares Held: 57K ($53K)
Q1 2025
Simplicity Wealth,Llc Shares Held: 30.3K ($28.2K)
Q1 2025
Envestnet Asset Management Inc Shares Held: 26.7K ($24.9K)

Top Sells

Q1 2025
Principal Financial Group Inc Shares Held: 92.4K ($85.9K)
Q1 2025
Victory Capital Management Inc Shares Held: 18.7K ($17.4K)
Q1 2025
Rhumbline Advisers Shares Held: 208K ($193K)
Q1 2025
Amalgamated Bank Shares Held: 4.68K ($4.35K)
Q1 2025
Alps Advisors Inc Shares Held: 117K ($109K)

About IRWD

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.


Insider Transactions at IRWD

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
951K Shares
From 13 Insiders
Grant, award, or other acquisition 951K shares
Sell / Disposition
518K Shares
From 10 Insiders
Open market or private sale 499K shares
Payment of exercise price or tax liability 18.3K shares

Track Institutional and Insider Activities on IRWD

Follow IRONWOOD PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IRWD shares.

Notify only if

Insider Trading

Get notified when an Ironwood Pharmaceuticals Inc insider buys or sells IRWD shares.

Notify only if

News

Receive news related to IRONWOOD PHARMACEUTICALS INC

Track Activities on IRWD